FDA DEVICE FACTS
BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini
Biofire Diagnostics, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The BIOFIRE® SPOTFIRE® Respiratory (R) Panel (SPOTFIRE R Panel) is a multiplexed polymerase chain reaction (PCR) test intended for use with the BIOFIRE® SPOTFIRE® System for the simultaneous, qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swab (NPS) specimens obtained from individuals with signs and symptoms of respiratory tract infection, including COVID-19.
The following organism types and subtypes are identified and differentiated using the SPOTFIRE R Panel:
Viruses Adenovirus Coronavirus (seasonal) Coronavirus SARS-CoV-2 Human metapneumovirus Human rhinovirus/enterovirus Influenza A virus Influenza A virus A/H1-2009 Influenza A virus A/H3 Influenza B virus Parainfluenza virus Respiratory syncytial virus
Bacteria Bordetella parapertussis Bordetella pertussis Chlamydia pneumoniae Mycoplasma pneumoniae
Nucleic acids from the viral and bacterial organisms identified by this test are generally detectable in NPS specimens during the acute phase of infection. The detection and The BIOFIRE® SPOTFIRE® Respiratory ® Panel Mini (SPOTFIRE R Panel Mini) is a multiplexed polymerase chain reaction (PCR) test intended for use with the BIOFIRE® SPOTFIRE® System for the simultaneous, qualitative detection and identification of multiple respiratory viral nucleic acids in nasopharyngeal swab (NPS) specimens obtained from individuals with signs and symptoms of respiratory tract infection, including COVID-19.
The following organism types are identified and differentiated using the SPOTFIRE R Panel Mini:
• Coronavirus SARS-CoV-2
• Human rhinovirus
• Influenza A virus
• Influenza B virus
• Respiratory syncytial virus
Nucleic acids from the viral organisms identified by this test are generally detectable in NPS specimens during the acute phase of infection. The detection and identification of specific viral nucleic acids from individuals exhibiting signs and/or symptoms of respiratory infection are indicative of the presence of the identified microorganism and aids in diagnosis if used in conjunction with other clinical and epidemiological information, and laboratory findings. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Negative results in the setting of a respiratory illness may be due to infection with pathogens BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini March 15, 2023 Page 4 identification of specific viral and bacterial nucleic acids from individuals exhibiting signs and/or symptoms of respiratory infection are indicative of the presence of the identified microorganism and aids in diagnosis if used in conjunction with other clinical and epidemiological information, and laboratory findings. The results of this test should not be used as the sole basis for diagnosis, treatment, or other patient management decisions. Negative results in the setting of a respiratory illness may be due to infection with pathogens that are not detected by this test, or lower respiratory tract infection that may not be detected by an NPS specimen. Positive results do not rule out coinfection with other organisms. The agent(s) detected by the SPOTFIRE R Panel may not be the definite cause of disease. Additional laboratory testing (e.g., bacterial and viral culture, immunofluorescence, and radiography) may be necessary when evaluating a patient with possible respiratory tract infection. that are not detected by this test, or lower respiratory tract infection that may not be detected by an NPS specimen. Positive results do not rule out coinfection with other organisms. The agent(s) detected by the SPOTFIRE R Panel Mini may not be the definite cause of disease. Additional laboratory testing (e.g., bacterial and viral culture, immunofluorescence, and radiography) may be necessary when evaluating a patient with possible respiratory tract infection.
Specimen Types Nasopharyngeal swab in transport media Same Organisms detected Viruses Adenovirus Coronavirus (seasonal) Coronavirus SARS-CoV-2 Human metapneumovirus Human rhinovirus/enterovirus Influenza A virus Influenza A virus A/H1-2009 Influenza A virus A/H3 Influenza B virus Parainfluenza virus Respiratory syncytial virus
Bacteria Chlamydia pneumoniae Mycoplasma pneumoniae Bordetella parapertussis Bordetella pertussis Viruses Coronavirus SARS-CoV-2 Human rhinovirus Influenza A virus Influenza B virus Respiratory syncytial virus
Analytes DNA/RNA RNA Technological Principles Highly multiplexed nested nucleic acid amplification test with melt analysis Same Instrumentation SPOTFIRE System Same Time to result About 15 minutes Same Reagent Storage Room Temperature Same Test Interpretation Automated test interpretation and reporting. User cannot access raw data. Same Controls Two controls are included in each reagent pouch to control for sample processing and both stages of PCR and melt analysis. Same User complexity Low (CLIA-waived) Same Panel Software Functions Defines panel-specific parameters, instrument protocols and report requirements. Same
Analyzes processed image data (fluorescence and temperature data) and provides test results. Same BIOFIRE® SPOTFIRE® Respiratory (R) Panel Mini March 15, 2023 Page 5 Summary of Performance Data: The performance data for the SPOTFIRE R Panel Mini is identical to the SPOTFIRE R Panel (K213954), but only contains data for the five analytes detected by the SPOTFIRE R Panel Mini (Coronavirus SARS-CoV-2, human rhinovirus, influenza A virus, influenza B virus, and respiratory syncytial virus). Please see the BIOFIRE SPOTFIRE Respiratory Panel Mini Instructions for Use for performance tables.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。